Occupational Asthma Management
DOI:
https://doi.org/10.58931/cait.2024.4372Abstract
Occupational asthma is defined as asthma that is caused by work exposures, accounting for approximately 10-15% of all new-onset adult asthma. Typically, this is a new-onset of asthma in workers with no previous history of asthma. However, the diagnosis may also be made in individuals who had previous childhood asthma that cleared, then recurred as an adult due to work exposure. In contrast, work-exacerbated asthma is defined as asthma that is exacerbated but not caused by work exposures.
Occupational asthma can be caused by different mechanisms (Figure 1). It is most often due to a workplace sensitizer, which is a high- or low-molecular weight agent that causes asthma from an immunologic response. Asthma symptoms do not occur on the first exposure. Instead, they require a period ranging from days to years for sensitization. Once sensitized, subsequent exposures, even to very low levels of exposure, will trigger asthma. When this response is due to high-molecular weight sensitizers, which are typically proteins or glycoproteins, it is associated with specific IgE antibodies. In addition, specific IgE-antibodies are also associated with the response to some low molecular-weight sensitizers (chemical sensitizers) such as complex platinum salts and other metal salts. However, for most low-molecular weight sensitizers, the immune mechanism is unclear.
References
Tarlo SM, Lemiere C. Occupational asthma. N Engl J Med 2014; 370:640-649.
Tarlo SM, Quirce S. Impact of identification of clinical phenotypes in occupational asthma. J Allergy Clin Immunol Pract. 2020;8(10):3277-3282.
Lantto J, Suojalehto H, Karvala K, Remes J, Soini S, Suuronen K, et al. Clinical Characteristics of Irritant-Induced Occupational Asthma. J Allergy Clin Immunol Pract. 2022;10(6):1554-61 e7. doi: 10.1016/j.jaip.2022.02.021
Vandenplas O, Wiszniewska M, Raulf M, de Blay F, Gerth van Wijk R, Moscato G, et al. EAACI position paper: irritant-induced asthma. Allergy. 2014;69(9):1141-1153.
Tarlo SM, Balmes J, Balkissoon R, Beach J, Beckett W, Bernstein D, et al. Diagnosis and management of work-related asthma: American College Of Chest Physicians Consensus Statement. Chest. 2008;134(3 Suppl):1S-41S.
Bernstein DI, Pacheco K, Lemiere C. How allergists can perform an occupational history in every patient. J Allergy Clin Immunol Pract. 2024;12(8):1951-1958.
Killorn KR, Dostaler SM, Olajos-Clow J, Turcotte SE, Minard JP, Holness DL, et al. The development and test re-test reliability of a work-related asthma screening questionnaire. J Asthma. 2015;52(3):279-288.
Barber CM, Cullinan P, Feary J, Fishwick D, Hoyle J, Mainman H, et al. British Thoracic Society Clinical Statement on occupational asthma. Thorax. 2022;77(5):433-442.
Cullinan P, Vandenplas O, Bernstein D. Assessment and management of occupational asthma. J Allergy Clin Immunol Pract. 2020;8(10):3264-3275.
Doyen V, Migueres N, Frere A, Walusiak-Skorupa J, Wiszniewska M, Suojalehto H, et al. Diagnostic Accuracy of Specific IgE Against Wheat and Rye in Flour-Induced Occupational Asthma. J Allergy Clin Immunol Pract 2024; 12:2017-25.
Venables KM, Tee RD, Hawkins ER, Gordon DJ, Wale CJ, Farrer NM, et al. Laboratory animal allergy in a pharmaceutical company. Br J Ind Med 1988; 45:660-6.
Henneberger PK, Patel JR, de Groene GJ, Beach J, Tarlo SM, Pal TM, et al. The effectiveness of removal from exposure and reduction of exposure for managing occupational asthma: Summary of an updated Cochrane systematic review. Am J Ind Med 2021; 64:165-9.
Tarlo SM, Banks D, Liss G, Broder I. Outcome determinants for isocyanate induced occupational asthma among compensation claimants. Occup Environ Med 1997; 54:756-61.
Suojalehto H, Lindstrom I. Long-term outcome of occupational asthma with different etiology. Curr Opin Allergy Clin Immunol 2024; 24:64-8.
Lantto J, Suojalehto H, Vasankari T, Karvala K, Lindstrom I. Long-Term Impairment From Irritant-Induced Occupational Asthma. J Occup Environ Med 2024; 66:597-603.
Tarlo SM, Liss GM, Yeung KS. Changes in rates and severity of compensation claims for asthma due to diisocyanates: a possible effect of medical surveillance measures. Occup Environ Med 2002; 59:58-62.